Deprodon

Deprodone is an active compound. Deprodone inhibits key processes such as bacterial cell wall synthesis by interacting with the hydrolase and transferase proteins of methicillin-resistant Staphylococcus aureus (MRSA) . Deprodone is used in research on anti-MRSA infection, inflammatory skin disorders, bowel disease, and fatty acid metabolism disorders[1].

20423-99-8

12352211

H302-H315-H319-H335

Bacterial

Anti-infection

COVID-19-immunoregulation

Infection; Inflammation/Immunology

C[C@@]12[C@](CC[C@]2(O)C(C)=O)([H])[C@@]3([H])[C@@]([C@H](C1)O)([H])[C@@]4(C(CC3)=CC(C=C4)=O)C

C21H28O4

344.44

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

[1]Almufarriji FM, et al. Unveiling the multitargeted potential of deprodone and control comparison with linezolid against hydrolase and transferase enzymes of methicillin-resistant Staphylococcus aureus. Int J Biol Macromol. 2024 Nov;279 (Pt 3) :135459.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-Z8025/

Reference compound1

No Development Reported